mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability

Abstract excerpt

Cancer cells have a characteristic metabolism, mostly caused by alterations in signal transduction networks rather than mutations in metabolic enzymes. For metabolic drugs to be cancer-selective, signaling alterations need to be identified that confer a druggable vulnerability. Here, we demonstrate that many tumor cells with an acquired cancer drug resistance exhibit increased sensitivity to mechanistically...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy in Disease and Therapy
• Share to Metabolism, Diabetes, and Cancer
• Share to Pancreatic function and diabetes